Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Colorectal Neoplasms 200Breast Neoplasms 124Carcinoma, Non-Small-Cell Lung 121Glioblastoma 93Neoplasms 75Ovarian Neoplasms 72Rectal Neoplasms 61Brain Neoplasms 59Lung Neoplasms 56Colonic Neoplasms 55Neoplasm Metastasis 51Glioma 49Carcinoma, Renal Cell 46Fallopian Tube Neoplasms 38Gliosarcoma 35Pancreatic Neoplasms 31Carcinoma, Hepatocellular 28Melanoma 26Adenocarcinoma of Lung 24Astrocytoma 21Stomach Neoplasms 20Uterine Cervical Neoplasms 16Recurrence 16Prostatic Neoplasms 16Liver Neoplasms 16Adenocarcinoma, Bronchiolo-Alveolar 16Esophageal Neoplasms 15Adenocarcinoma 15Carcinoma, Ovarian Epithelial 14Kidney Neoplasms 13

Interventions

Surveys and Questionnaires 3pazopanib 2Oxaliplatin 2Erlotinib Hydrochloride 2Cetuximab 2Bevacizumab 2satraplatin 1ixazomib 1Vorinostat 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Platinum 1Leucovorin 1Lapatinib 1LY 2275796 1Fluorouracil 1Everolimus 1Capecitabine 1Azacitidine 1Albumin-Bound Paclitaxel 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Advanced Cancers × Bevacizumab × Clear all
NCT01213238 2019-03-15

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab

M.D. Anderson Cancer Center

Phase 1 Completed
116 enrolled

Advanced Cancers

NCT00941499 2015-11-18

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

M.D. Anderson Cancer Center

Phase 1 Completed
140 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡